1. Academic Validation
  2. Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells

Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells

  • J Agric Food Chem. 2019 Feb 13;67(6):1656-1665. doi: 10.1021/acs.jafc.8b05447.
Long Ma 1 Xiuqi Cao 1 Haiyue Wang 1 Kui Lu 1 Ying Wang 1 Chunhao Tu 1 Yujie Dai 1 Yuanyuan Meng 1 Yuyin Li 1 Peng Yu 1 Shuli Man 1 Aipo Diao 1
Affiliations

Affiliation

  • 1 State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Fermentation Microbiology (MOE), Tianjin Key Laboratory of Industrial Microbiology, School of Biotechnology , Tianjin University of Science & Technology , Tianjin 300457 , China.
Abstract

Human FLAP endonuclease 1 (hFEN1) is instrumental in DNA replication and repair. It is able to cleave the 5' single-stranded protrusion (also known as 5' FLAP) resulting from strand displacement reactions. In LIGHT of its crucial functions, hFEN1 is now deemed as a nontrivial target in the DNA damage response system for Anticancer drug development. Herein, we report that myricetin and some natural Flavonoids are able to inhibit hFEN1. Structure-activity relationship, inhibitory mechanisms, molecular docking, and Cancer cell-based assays have been performed. Our original findings expand the activity of Flavonoids and may pave the way for flavonoid-assisted targeted Cancer therapy.

Keywords

colon cancer treatment; flavonoids; human flap endonuclease 1 (hFEN1); inhibitor; molecular docking; myricetin; sensitizing effect; structure−activity relationship analysis.

Figures
Products